Cargando…

PD-L1 expression in malignant salivary gland tumors

BACKGROUND: Programmed death-1 ligand-1 (PD-L1) an important cancer biomarker that can suppress the immune system and its high expression is often reported to be related with increased tumor aggressiveness in some cancers. Here, we examined and evaluated PD-L1 expression in patients with malignant s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harada, Koji, Ferdous, Tarannum, Ueyama, Yoshiya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801834/ https://www.ncbi.nlm.nih.gov/pubmed/29409471 http://dx.doi.org/10.1186/s12885-018-4069-3

Ejemplares similares

Therapeutic strategies with oral fluoropyrimidine anticancer agent, S-1 against oral cancer()
por: Harada, Koji, et al.
Publicado: (2017)

Low carbonyl reductase 1 expression is associated with poor prognosis in patients with oral squamous cell carcinoma
por: Yamanouchi, Ryota, et al.
Publicado: (2018)

Elemental Diet Accelerates the Recovery From Oral Mucositis and Dermatitis Induced by 5-Fluorouracil Through the Induction of Fibroblast Growth Factor 2
por: Harada, Koji, et al.
Publicado: (2017)

Osteogenic cell fractions isolated from mouse tongue muscle
por: HARADA, KOJI, et al.
Publicado: (2015)

Gimeracil enhances the antitumor effect of cisplatin in oral squamous cell carcinoma cells in vitro and in vivo
por: Harada, Koji, et al.
Publicado: (2017)

An elemental diet protects mouse salivary glands from 5-fluorouracil-induced atrophy
por: Harada, Koji, et al.
Publicado: (2022)

The expression of PD-L1 in salivary gland carcinomas
por: Vital, Domenic, et al.
Publicado: (2019)

Antitumor effects of bevacizumab in combination with fluoropyrimidine drugs on human oral squamous cell carcinoma
por: Itashiki, Yasutaka, et al.
Publicado: (2021)

Induction of artificial cancer stem cells from tongue cancer cells by defined reprogramming factors
por: Harada, Koji, et al.
Publicado: (2016)

MTA1 Expression in Benign and Malignant Salivary gland Tumors
por: Andisheh-Tadbir, Azadeh, et al.
Publicado: (2016)

Overexpression of PD-L2 is associated with shorter relapse-free survival in patients with malignant salivary gland tumors
por: Chang, Hyeyoon, et al.
Publicado: (2017)

Expression of Paxillin in Benign and Malignant Salivary Gland Tumors
por: Andisheh–Tadbir, Azadeh, et al.
Publicado: (2019)

A benign salivary gland tumor of minor salivary gland mimicking an epithelial malignancy
por: Reddy, Vandana, et al.
Publicado: (2015)

Incidence and Prognostic Significance of PD-L1 Expression in High-Grade Salivary Gland Carcinoma
por: Fang, Qigen, et al.
Publicado: (2021)

Metachronous malignant tumors in ipsilateral salivary glands
por: Kwon, Hyo Jeong, et al.
Publicado: (2019)

Corrigendum: Incidence and Prognostic Significance of PD-L1 Expression in High-Grade Salivary Gland Carcinoma
por: Fang, Qigen, et al.
Publicado: (2021)

Malignant tumours of the salivary glands
por: Bensadoun, R J, et al.
Publicado: (2001)

Malignant mixed tumor in the salivary gland of a cat
por: Kim, Heejaung, et al.
Publicado: (2008)

The efficacy of PD‐1 inhibitors in patients with salivary gland carcinoma: A retrospective observational study
por: Sato, Ryosuke, et al.
Publicado: (2022)

Prognostic role of PD-L1 expression in patients with salivary gland carcinoma: A systematic review and meta-analysis
por: Wu, Limeng, et al.
Publicado: (2022)

Salivary Heparanase Level Is a Potential Biomarker to Diagnose and Prognose the Malignant Salivary Gland Tumor
por: Wu, Xiangbing, et al.
Publicado: (2015)

The Periphery of Salivary Gland Carcinoma Tumors Reveals a PD-L1/PD-1 Biomarker Niche for the Evaluation of Disease Severity and Tumor—Immune System Interplay
por: Kuchar, Martin, et al.
Publicado: (2021)

EZH2 is a sensitive marker of malignancy in salivary gland tumors
por: Hajósi-Kalcakosz, Szofia, et al.
Publicado: (2015)

Prognostic significance of FOXM1 in oral squamous cell carcinoma patients treated by docetaxel-containing regimens
por: Harada, Koji, et al.
Publicado: (2019)

The Impact of Angiogenesis in the Most Common Salivary Gland Malignant Tumors
por: Pouloudi, Despoina, et al.
Publicado: (2020)

The role of immune surveillance in malignant transformation of benign salivary gland tumors
por: Linxweiler, Maximilian, et al.
Publicado: (2021)

Glutamine is essential for overcoming the immunosuppressive microenvironment in malignant salivary gland tumors
por: Cao, Shuting, et al.
Publicado: (2022)

Prognostic Impact of PD-L1 Expression in Malignant Salivary Gland Tumors as Assessed by Established Scoring Criteria: Tumor Proportion Score (TPS), Combined Positivity Score (CPS), and Immune Cell (IC) Infiltrate
por: Witte, Hanno M., et al.
Publicado: (2020)

Overexpression of CDC7 in malignant salivary gland tumors correlates with tumor differentiation()
por: Jaafari-Ashkavandi, Zohreh, et al.
Publicado: (2017)

Expression of N-Cadherin in Salivary Gland Tumors
por: Kehagias, N., et al.
Publicado: (2012)

Increased Mast Cell Counts in Benign and Malignant Salivary Gland Tumors
por: Jaafari-Ashkavandi, Zohreh, et al.
Publicado: (2014)

Comparison of the expression of 5 heat shock proteins in benign and malignant salivary gland tumor tissues
por: WANG, GUILAN, et al.
Publicado: (2013)

Stromal and epithelial syndecan-1 expression in benign and malignant salivary gland tumors: which is more reflective of behavior?
por: Alaeddini, Mojgan, et al.
Publicado: (2019)

Giant Eccrine Hidradenoma Mimicking a Malignant Tumor of the Salivary Gland
por: Oh, Seung Hyun, et al.
Publicado: (2014)

Second primary malignancies following salivary gland cancers.
por: Biggar, R. J., et al.
Publicado: (1983)

PLAG1, SOX10, and Myb Expression in Benign and Malignant Salivary Gland Neoplasms
por: Lee, Ji Hyun, et al.
Publicado: (2019)

Nuclear hBD-1 accumulation in malignant salivary gland tumours
por: Wenghoefer, M, et al.
Publicado: (2008)

MICROCALCIFICATIONS IN SALIVARY GLAND TUMORS
por: Bavle, Radhika M
Publicado: (2014)

Serum Levels of Cyfra 21 in Patients with Benign and Malignant Salivary Gland Tumors
por: Jeiroodi, Naghmeh, et al.
Publicado: (2017)

CD73 a novel marker for the diagnosis of benign and malignant salivary gland tumors
por: Ranjbar, Mohammad-Ali, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ikl2m6htla9lc0mm512d52dg3r